The Manila Times1d
Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
"We are pleased that Oaktree and OMERS recognize the ongoing success of the Ohtuvayre™ (ensifentrine) launch and continued ...
Vast Granted Qualified Infectious Disease Product Designation from the FDA
Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has ...
Insmed to Present 11 Abstracts from Across Its Respiratory Portfolio at the American Thoracic Society 2025 International Conference
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
The Lancet5d
Targeting neutrophil serine proteases in bronchiectasis—where are we now?
Over the past decades, bronchiectasis has been neglected, despite the global burden.1,2 To date, better diagnosis due to easy ...
The DWP PIP benefits still paid to people with these 27 NHS health conditions
The DWP will hand out the boost next month to increase the amount paid to people claiming Personal Independence Payments ...
Everyone with these 27 NHS health conditions can still get £812 DWP PIP benefits
The DWP's PIP benefits are still available despite potential changes and could get you £812 a month if you have one of these ...
Le Lézard9d
Armata Pharmaceuticals Announces Fourth Quarter and Full-Year 2024 Results and Provides Corporate Update
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
EurekAlert!18d
Thirty-three centers join new Bronchiectasis and NTM Care Center Network
The Bronchiectasis and NTM Association has accepted 27 Care Center and six Clinical Associate Center sites in 23 states and the District of Columbia into the new Bronchiectasis and NTM Care Center ...
Healio19d
25.4% of patients with bronchiectasis had symptoms for more than 10 years before diagnosis
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. This study cohort was made up of 71.3% U.K. patients ...